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Abstract
Objective: The aim of this study was to compare conventional surgery with carbon dioxide (CO2) laser in patients 
with oral leukoplakia, and to evaluate the postoperative pain and swelling. 
Study design: A total of 48 patients (27 males and 21 females) with a mean age of 53.7 ± 11.7 years and diagnosed 
with oral leukoplakia were randomly assigned to receive treatment either with conventional surgery using a cold 
knife or with a CO2 laser technique. A visual analog scale (VAS) was used to score pain and swelling at different 
postoperative time points. 
Results: Pain and swelling reported by the patients was greater with the conventional cold knife than with the CO2 
laser, statistically significant differences for pain and swelling were observed between the two techniques during 
the first three days after surgery. Followed by a gradual decrease over one week. In neither group was granuloma 
formation observed, and none of the patients showed malignant transformation during the period of follow-up. 
Conclusions: The CO2 laser causes only minimal pain and swelling, thus suggesting that it may be an alternative 
method to conventional surgery in treating patients with oral leukoplakia.
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Introduction
Oral leukoplakia is a predominantly white lesion of the 
oral mucosa that cannot be characterized as any other 
definable lesion; some oral leukoplakias will transform 
into cancer (1-6). The estimated worldwide prevalence 
of oral leukoplakia is approximately 2% (3). There are 
some geographical differences with regard to the gender 
distribution of the disease (2), and leukoplakia is moreo-
ver much more common among smokers than among 
non-smokers. Alcohol is thought to be an independent 
risk factor, but definitive data are still lacking. Actu-
ally, there are conflicting results of studies related to the 
possible role of human papillomavirus (HPV) infection 
(1,5). Histologically, leukoplakia is an intraepithelial le-
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Fig. 1. Oral leucoplakia of the gums (before the surgical 
treatment).
Fig. 2. Oral leukoplakia of the gums (immediately after 
the surgical treatment with CO2 laser).
sion consisting of epithelial hyperplasia, with or with-
out hyperkeratosis and minimal inflammation, and with 
or without varying degrees of dysplasia (2,6).
As regards the treatment of oral leukoplakia, interven-
tion first should focus on the associated risk factors: 
with the suppression of smoking, alcohol abuse, and 
local irritating factors and overinfections. The second 
intervention, when the associated risk factors have been 
eliminated, it must be the oral biopsy. A number of treat-
ment regimens have been proposed for oral leukoplakia 
without dysplasia, including surgical techniques such 
as scalpel excision, electrocoagulation, cryotherapy and 
laser CO2 therapy and also medical treatments such as 
vitamin A and retinoids, antioxidants and topical bleo-
mycin (1,7-17). Leukoplakia is considered to be the most 
common potentially malignant disorder of the oral mu-
cosa, the reported malignant transformation rates vary 
from 1.2-9% and the recurrence rates for oral leukopla-
kia vary from 7.7-38.1% (18-25).
The CO2 laser is currently accepted as the technique of 
choice in the management of oral leukoplakia and some 
malignant oral lesions (26), compared with the cold scal-
pel. In this context, the CO2 laser affords a haemostatic 
effect (in coagulation or haemostatic mode) particularly 
useful in highly vascularized areas, this result in a clearer 
surgical field and therefore a reduction in operating time. 
This laser can also be used for the treatment of superficial 
oral mucosa lesions (in section or cut mode).
Some authors have examined postoperative pain in the 
surgical treatment of soft tissue lesions (11,20), though 
there are few comparative studies on the different sur-
gical techniques in relation to postoperative pain and 
swelling in oral leukoplakia patients.
The aim of the present study was to compare conven-
tional cold knife surgery with the CO2 laser in patients 
with oral leukoplakia, and to evaluate pain and swelling 
during the first postoperative week.
Material and Methods
-Study subjects
A total of 48 patients with oral leukoplakia who went to 
the Department of Oral Medicine of the University Clinic 
of Dentistry of the University of Murcia (Spain) between 
January of 2005 and December of 2010 were enrolled 
into the study, and the study was approved by the Ethics 
Committee of the University of Murcia. All patients had 
an incisional biopsy performed under local anesthesia 
prior to surgical treatment. The clinical diagnosis of the 
lesions was based on the criteria proposed by Axell et al. 
(5), adopted by the World Health Organization (WHO), 
and the histopathological diagnosis of epithelial dysplasia 
was established according to WHO definitions (3).
Informed consent was obtained from all patients before 
inclusion in the study. The patients received a complete 
physical head and neck examination. The possible etio-
logical factors smoking and alcohol were identified, and 
advice on risk factor elimination was given before sur-
gical treatment. The lesions were classified according 
to location and clinical appearance. All surgeries were 
performed by the same surgeon and carried out under 
local anesthesia with 4% articaine and 1:100,000 adre-
nalin (Inibsa; Lliça de Vall, Barcelona, Spain).
The patients were randomized (with an informatics 
system) by receiving stamped envelopes containing the 
numbers 1 or 2, indicating which group they would be 
placed in. Group 1 (17 males and 11 females) was treat-
ed by standard cold knife surgery. Group 2 (10 males 
and 10 females) was treated by CO2 laser (Lasersat 
20W, Satelec®, Pierre Rolland, SATELEC®, S.A., Bar-
celona, Spain). Appropriate safety regulations for the 
use of lasers were followed by the operating personnel 
and patients (protective glasses and limited access to 
the surgical area). 
In group 1, the lesions were excised with a cold knife 
including 3 mm of clinically normal mucosa at the peri-
phery. In group 2, the lesions were excised with CO2 la-
ser in continuous mode, defocalized, with 15 mm of dis-
tance focus-lesion and a power setting of 5-15 W (5-15 
seconds) (including, 3 mm of clinically normal mucosa 
at the periphery) (Figs. 1,2).
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Table 1. Homogeneity of the study groups in terms of the demographic characteristics, lesion location, size, and histological charac-
teristics (Mann-Whitney U-test and Pearson χ2 test).
CO2 laser (n=20) Cold scalpel (n=28) p-value
Age: median (range) 54.0 (34-74) 57.0 (28-67) 0.592
Sex: n (%) 0.461
Male 10 (50.0) 17 (60.7)
Female 10 (50.0) 11 (39.3)
Location: n (%) 0.257
Cheek mucosa 5 (25.0) 5 (17.8)
Gums 8 (40.0) 16 (57.1)
Palate 3 (15.0) 5 (17.8)
Tongue 1 (5.0) 2 (7.3)
Floor of the mouth 3 (15.0) 0 (0)
Size (cm): n (%) 0.072
<2 18  (90.0) 19 (67.8)
2-4 2 (10.0) 9 (32.2)
>4 0 (0) 0 (0)
Dysplasia 0.471
No 15 (75.0) 23 (82.1)
Little 4 (20.0) 5 (17.9)
Moderate 1 (5.0) 0 (0)
Severe 0 (0) 0 (0)
In group 1, the wounds were closed with 3/0 sterile su-
ture (Laboratories Normon®, Madrid, Spain); but in 
group 2 the wounds regeneration were by second inten-
tion healing.
A VAS of 100 mm in length was used to evaluate the 
intensity of pain and swelling. This scale converted the 
visual analogical evaluation made by the patient into a 
numerical value: from 0 (corresponding to 0 mm on the 
VAS and showed no pain and no swelling) to 10 (100 
mm on the VAS and showed unbearable pain and maxi-
mal swelling). Each patient was told how to use the VAS 
and was asked to mark the intensity of pain and swell-
ing 12 and 24 hours after surgery and then on each day 
for the following 6 days. After the surgical intervention, 
600 mg of Ibuprofen was prescribed every 8 hours for 
the first four postoperative days. Finally, the patients 
were revised at 7 days after treatment.
-Statistical analysis
Data were analyzed using the SPSS version 12.0 sta-
tistical package (SPSS® Inc., Chicago, IL, USA). A 
descriptive study was made of each variable. The 
Kolmogorov-Smirnov normality test and Levene 
variance homogeneity test were applied, and the data 
showing a skewed distribution were analyzed using 
a nonparametric ranking test. The associations be-
tween the different qualitative variables were stud-
ied using Pearson’s chi-squared test. We used the 
Kruskal-Wallis test (for more than two samples), the 
Mann-Whitney U-test (for two independent samples) 
and the Wilcoxon test (for two related samples), for 
quantitative variables. A probability p£0.05 was ac-
cepted as significant.
Results
The mean sample age was 53.7 ± 11.7 years (range 28-
74). As regards the oral leukoplakia risk factors, 39 of the 
48 patients included in the study (81.3%) were cigarette 
smokers while 9 (18.8%) were non-smokers. Alcohol con-
sumption was generally mild: social alcohol consump-
tion (1 or 2 units per day) was recorded for 17 patients 
(35.4%), while 31 reported no alcohol intake (64.6%). 
With respect to the clinical presentation of the lesions, 
46 were homogeneous leukoplakias and 2 were no-ho-
mogeneous leukoplakias.
The lesions were distributed as follows: 10 in cheek mu-
cosa (20.8%), 24 in gums (50%), 8 in palate (16.8%), 3 in 
tongue (6.2%) and 3 in floor of the mouth (6.2%).
The two study groups (cold knife and CO2 laser) were 
homogeneous in terms of patient age (p=0.592), gen-
der (p=0.461), location (p=0.257), extent of the lesions 
(p=0.072) and the presence of dysplasia (p=0.471) (Ta-
ble 1). 
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The mean duration of follow-up was 27.90 ± 12.05 months 
(range 1-40) (Fig. 3). In neither group was granuloma for-
mation observed, and none of the patients showed malig-
nant transformation during the period of follow-up.
Pain and swelling reported by the patients was greater with 
the cold knife than with the CO2 laser, with statistically 
significant differences between the two techniques during 
the first three days after surgery (p-value for related sam-
ples at 12h, 1, 2 and 3 days ≤ 0.05). Followed by a gradual 
decrease over one week in both groups (Table 2).
In the CO2 laser group, on comparing the median (range) 
pain scores (recorded at peak pain intensity: between 12-
24 hours after surgery) and swelling scores (recorded at 
peak swelling intensity: between 12-48 hours after sur-
gery), statistically significant differences were observed 
for pain (p=0.021) and swelling (p=0.019) with respect 
to lesion size (Table 3).
In turn, in the cold knife group, on comparing the me-
dian pain scores (recorded at peak pain intensity: 12 
hours after surgery) and swelling scores (recorded at 
peak swelling intensity: 24 hours after surgery) no sta-
tistically significant differences were observed for the 
variables studied (Table 4).
Fig. 3. Box-plot with the time of follow-up of both 
study groups (group 1 = cold knife and group 2 = CO2 
laser).
Seven days 
after surgery         
Pain CO2 laser (n=20) 
median (range)
Pain cold scalpel (n=28)  
median (range)
p-value
12 hours                              2.5 (0-8) 20.0 (0-70) 0.001
1 day                                   2.5 (0-7) 15.0 (0-63) 0.001
2 days                                 1.5 (0-8) 12.5 (0-52) 0.003
3 days                                 0.5 (0-9) 9.5 (0-52) 0.029
4 days                                 0.0 (0-10) 3.5 (0-45) 0.116
5 days 0.0 (0-10) 0.0 (0-45) 0.284
6 days 0.0 (0-10) 0.0 (0-46) 0.159
7 days 0.0 (0-10) 0.0 (0-29) 0.796
Seven days  
after surgery         
Swelling CO2 laser (n=20)  
median (range)
Swelling cold scalpel 
(n=28) median (range)
p-value
12 hours                              2.0 (0-9) 10.0 (0-75)        <0.001
1 day 2.0 (0-8) 15.0 (0-73) 0.008
2 days                                 2.0 (0-7) 10.0 (0-65) 0.007
3 days                                 1.5 (0-6) 10.0 (0-43) 0.019
4 days                                 0.0 (0-4) 0.0 (0-40) 0.365
5 days                                 0.0 (0-3) 0.0 (0-40) 0.161
6 days                                 0.0 (0-3) 0.0 (0-30) 0.051
7 days                                 0.0 (0-2) 0.0 (0-10) 0.407
Table 2. Incidence and severity of pain and swelling during the 7 days after oral leukoplakia removal  (Mann-
Whitney U-test). 
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Table 3. Comparison of median (range) pain scores (recorded at peak pain intensity: between 12-24 hours after surgery) and swelling 
scores (recorded at peak swelling intensity: between 12-48 hours after surgery) in the CO2 laser group (Kruskal-Wallis and Mann-
Whitney U-test). 
Characteristics Pain score median 
(range)
p-value Swelling score me-
dian (range)
p-value
Age group                            0.587 0.365
≤40  3.0 (0-5) 1.0 (0-3)
41-60  3.0 (0-7) 3.0 (0-7)
≥61                                   1.0 (0-7) 0.5 (0-8)
Sex 0.817 0.224
Male 2.0 (0-7) 1.0 (0-8)
Female 2.5 (0-7) 3.0 (0-7)
Smoking habit                        1.000 0.922
Yes 2.5 (0-7) 2.0 (0-8)
No 2.0 (0-6) 1.5 (0-6)
Location 0.085 0.380
Cheek mucosa                  3.0 (1-7) 2.0 (0-8)
Gums 0.0 (0-3) 2.5 (0-4)
Palate 4.0 (1-5) 0.0 (0-2)
Tongue 6.0 (6-6) 6.0 (6-6)
Floor of the mouth            3.0 (0-5) 0.0 (0-4)
Size (cm)                               0.021 0.019
   <2                                      1.5 (0-6) 1.5 (0-6)
2-4                                     7.0 (7-7) 7.5 (7-8)
>4                                        ------- -------
Dysplasia 0.900 0.798
No 2.0 (0-7) 2.0 (0-8)
Yes 2.5 (0-7) 1.0 (0-7)
Discussion
The present study involves two groups of patients with 
oral leukoplakia: one subjected to conventional surgi-
cal treatment with a cold knife and the other to CO2 la-
ser surgery. In both groups the postoperative pain and 
swelling were evaluated. 
The CO2 laser is currently accepted as the technique of 
choice in the management of many soft tissue lesions 
in the oral and maxillofacial regions. Compared to the 
scalpel, the CO2 laser affords a hemostatic effect par-
ticularly in highly vascularized areas. This in turn re-
sults in a clearer surgical field and therefore a reduction 
in operating time. Treatment with the laser has certain 
advantages, such as the selective removal of affected 
epithelium and minimal damage to surrounding healthy 
tissue, resulting in excellent wound healing with mini-
mal or no scar tissue, and a good functional outcome 
(15-19). Other favorable features of CO2 laser therapy 
may include reduced postoperative pain and swelling.
In our study, the patients with oral leukoplakias treated 
with CO2 laser showed a lower postoperative pain and 
swelling than the patients treated with a cold knife, with 
statistically significant differences during the first three 
days after surgery. None of the patients showed ma-
lignant transformation during the period of follow-up 
(27.90 ± 12.05). Nevertheless, Schoelch et al. (20), after 
surgery treatment of 70 oral leukoplakias (48 homoge-
neous leukoplakia, 8 erythroleukoplakia and 14 verru-
cous leukoplakias) by mean CO2 laser, with a mean of 
period of follow-up of 32 months (range 6-178 months) 
saw that 5 patients (7.14%) developed a squamous cell 
carcinoma at the lesion site.
The most important disadvantage of CO2 laser evapo-
ration of oral leukoplakia is the fact that the lesion is 
not available for histological study, in this sense an inci-
sional presurgical biopsy must be obtained in all cases. 
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The location of the lesion therefore must be carefully 
chosen. If the lesion is large or shows different clinical 
aspects, more than one biopsy is recommended (17-20).
One characteristic difference between the CO2 laser 
and cold knife is the generation of a coagulated tissue 
layer along the walls of the laser incision. This zone of 
thermal damage may impede the graft consolidation 
and reduce tensile strength during the period of wound 
healing, especially in extensive zones (17).
Measurement of postoperative pain is inherently diffi-
cult, as it comprises both physical and psychological as-
pects. Subjectively, the true character of pain experience 
is not directly accessible to the examiner. Therefore, the 
examiner must rely on the patient’s ability to commu-
nicate his or her perception and interpretation of the 
pain. In the laser group, on comparing the pain scores 
(recorded at peak pain intensity: between 12-24 hours 
after surgery) and swelling scores (recorded at peak 
swelling intensity: between 12-48 hours after surgery), 
no statistically significant differences were observed in 
relation to age, gender, smoking habit, location of lesion 
or dysplasia presence. Nevertheless, statistically signifi-
cant differences were observed with respect to lesion 
size, with more pain and swelling in the most extensive 
lesions. In this sense, Van de Hem et al. (22), after surgi-
cal treatment of 282 oral leukoplakias (in 200 patients) 
with CO2 laser saw that the patients with most extensive 
lesions (≥2 cm) showed higher postoperative pain, and 
they recommended the vaporization in several sessions 
in patients with extensive lesions.
The main problem of oral leukoplakia is its possible ma-
lignant transformation, reported to occur in 1.2-9% of 
cases (6,19, 24). Holmstrup et al. (18) found no evidence 
that surgical treatment is protective against cancer de-
velopment and reported that surgical intervention does 
not appear to prevent oral premalignant lesions from 
developing into malignancy. 
In an observational retrospective study published by 
Schepman et al. (23) compared the incidence of squa-
mous cell carcinomas in two groups of subjects with 
Table 4. Comparison of median (range) pain scores (recorded at peak pain intensity 12 hours after surgery) and swelling scores 
(recorded at peak swelling intensity 24 hours after surgery) in the cold scalpel group (Kruskal-Wallis and Mann-Whitney U-test). 
Characteristics Pain score median 
(range)
p-value Swelling score me-
dian (range)
p-value
Age group                            0.240                           0.145
≤40  20.0 (20-63)                    20.0 (20-60)
41-60  10.0 (0-70)                      6.0 (0-73)     
≥61                                   38.0 (0-40)                    33.0 (0-35)      
Sex 0.433                           0.738                           
Male 7.0 (0-70)                     20.0 (0-73)
Female 20.0 (10-30)                   10.0 (0-50)  
Smoking habit                        0.606                           0.483        
Yes 20.0 (0-70)                     20.0 (0-73)
No 10.0 (10-38) 10.0 (10-35)                    
Location 0.694                           0.095          
Cheek mucosa                  10.0 (0-27)                      2.0 (0-20)                   
Gums 23.5 (0-70)                     20.0 (0-73)        
Palate 20.0 (7-63)                     20.0 (2-60)             
Tongue 23.5 (0-27) 0.0 (0-0)                    
Floor of the mouth            --------                         --------                         
Size (cm)                               0.842 0.708           
<2                                      10.0 (0-70)                     10.0 (0-73)              
2-4                                     20.0 (0-63)                     20.0 (0-60)  
>4                                        --------  --------  
Dysplasia 0.904                           0.692                     
No 20.0 (0-63)                     20.0 (0-60)                       
Yes 27.0 (0-70)                     10.0 (0-73)            
Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e38-44.                                                                                                                                                      Oral leukoplakia treatment with CO2 laser
e44
oral leukoplakia: one comprising patients who received 
some type of active treatment (medical and/or surgical) 
and the other involving patients kept under regular clini-
cal follow-up. No significant difference was observed in 
the risk of malignant transformation between the two 
groups. These results, perhaps suggesting that the natural 
history of oral leukoplakias might be independent of the 
treatment received and that there is a subgroup of lesions 
destined to undergo malignant transformation regardless 
of the therapeutic strategy adopted. Nevertheless, we al-
ways must realise a detailed study of the lesions and the 
higher risk lesions must be actively treated.
To date, our experience with the surgical removal of 
oral leukoplakia has been satisfactory with both of the 
described techniques in this study. Nevertheless, the 
studied sample is small and the follow-up period brief. 
These limitations must be taken into account and stud-
ies involving larger patient series and regular follow-up 
over longer periods of time are needed in order to derive 
more reliable information on the role of invasive surgi-
cal resection in the prevention of oral cancer in patients 
with oral leukoplakia. 
In the present study, we found the CO2 laser to cause 
only minimal pain and swelling, thus suggesting that it 
may be an alternative method to conventional surgery 
in treating patients with oral leukoplakia.
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